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ABSTRACT 
Purpose: To determine changes in macular thickness following uneventful cataract 
surgery, to elucidate the optical tomographic features of macular thickness after 
uneventful cataract surgery and to compare the changes in macular thickness 
following uneventful phacoemulsification and manual small incision cataract 
surgery. 
 Methods: A total of fifty patients (28 males and 22 females), ranging in age from 35 to 78 years 
(mean age 58.6 years) were enrolled in the study. Of these, 25 (50% of total) individuals 
underwent small incision cataract surgery (SICS) in one eye with “in the bag” polymethacrylate 
intraocular lens (PMMA IOL) implantation, while the other 25 (50% of total) individuals 
underwent phacoemulsification in one eye with “in the bag” acrylic type of foldable IOL.  
Exclusion criteria were cataract too dense for pre-operative OCT, retinal pathology, traumatic or 
complicated cataract and complication during surgery. Best corrected visual acuity was 
measured; OCT was done pre and post–operative periods for macular thickness. Follow up of the 
patients was done at one, two and four weeks after the surgery and also three months after 
surgery.                    
 Results: In the 50 patients, who underwent cataract surgery, subclinical macular oedema was 
noted at the first, second and fourth week reviews; the peak subclinical macular odema was 
noted at the first week review. However, at the third month review, the macular edema had 
reduced. Highly significant (P<0.01) or significant (P<0.05) differences  were noted between the 
preoperative mean value and the post-operative 1st week mean value , preoperative mean value 
and the post-operative 2nd week mean value, and the  preoperative mean value and the post-
operative 4th week mean value of macular thickness. In SICS group Highly significant (P<0.01) 
or significant (P<0.05) differences  were noted between the preoperative mean value and the 
post-operative 1st week mean value , preoperative mean value and the post-operative 2nd week 
mean value, and the  preoperative mean value and the post-operative 4th week mean value of 
macular thickness.  In Phaco group Significant (P<0.05) differences  were noted between the 
preoperative mean value and the post-operative 1st week mean value , preoperative mean value 
and the post-operative 2nd week mean value, and the  postoperative 1st week mean value and the  
post-operative 4th week mean value of macular thickness. There was a significant subclinical 
change in the macular thickness without affecting the visual acuity. Cystoid macular edema was 
not noted in any of the patients in the current study. When both the groups were compared, a 
prolonged subclinical macular oedema was noted up to the fourth week review in the SICS group 
whereas in the patients who had undergone phacoemulsification, the macular thickness was 
found to be increased up to the second week review. However, differences between the two 
groups in the mean macular thickness values noted preoperatively (`t’ (d.f.=48)= 0.96; P>0.05) 
and at 1 week(`t’ (d.f.=48)= 1.06; P>0.05), 2 weeks(`t’ (d.f.=48)= 0.73; P>0.05), 4 weeks(`t’ 
(d.f.=48)= 0.62; P>0.05) and 3 months (`t’ (d.f.=48)= 0.24; P>0.05)postoperatively were not 
statistically significant. 
Conclusion 
Subclinical macular edema occurs after uncomplicated cataract surgery with a peak at 1 week 
after surgery and can last for up to 4 weeks. OCT showed macular edema without altering the 
architecture of the macula. The duration of the subclinical edema is longer in eyes undergoing 
manual SICS as compared to those undergoing phacoemulsification. There is no effect of this 
edema on visual acuity. 
Key words: SICS small incision cataract surgery OCT optical coherence tomography PMMA 
IOL polymethacrylate intraocular lens  
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INTRODUCTION 
 
 High resolution cross-sectional imaging of the retina is useful for 
identifying, monitoring and quantitatively assessing macular thickness. 
Optical coherence tomography (OCT) is a medical diagnostic imaging 
technology which can perform micron resolution, cross sectional or 
tomographic imaging in biological tissues. Cross-sectional images of the 
retina are obtained at the resolution of 10 microns. OCT uses low 
coherence or white light-interferometry to perform high resolution 
measurements and imaging. The infra red light beam has a wave length of 
820nm. Post-operative changes in macular thickness occur following 
cataract surgery. Subclinical changes in macular thickness, without 
affecting visual acuity occur and these changes can be assessed by OCT.¹ 
Pseudophakic cystoid macular edema (PCME) is a common complication 
of cataract and intraocular lens (IOL) surgery, manifesting as effusion of 
fluid from the capillaries. Cystoid  spaces form in the macula due the 
accumulation of serous fluid in the outer plexiform layer. This 
phenomenon is most often self-limiting, culminating in spontaneous 
resolution, but occasionally leads to marked impairment of central vision, 
which may become chronic or permanent.  
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Anatomy of the macula 
 The retina is divided into two regions, namely, a central area 
measuring 5 to 6 mm and a peripheral large area surrounding it. The 
central area, the area centralis,² a more  vague areal concept, is the macula 
lutea.³ The macular area is elliptical, being slightly less in the vertical than 
in the horizontal direction .The transverse diameter of the intensely 
pigmented central portion is estimated to be 3mm.4  The surrounding, 
faintly yellow zone, is about 1mm wide, the diameter of the entire area 
thus being 5mm. The central area itself can be divided into three areas, the 
central fovea and two concentric bands surrounding it, the parafovea and 
the perifovea.  The fovea is a shallow rounded pit. The fovea centralis is 
on the temporal side of the optic disc and about is 0.8mm5; its shape is that 
of a shallow bowl with a concave floor. In the centre of the floor is a slight 
dip, the foveola,6 in the midst of which is a small central concavity, the 
umbo.  The parafovea is a belt 2.1 mm wide around the fovea while the 
perifovea forms a further belt about 1.5mm.   
 
Etiopathogenesis 
 A break in the blood- aqueous barrier has been identified as the 
prime cause of PCME. There is breakdown of the junction complexes of 
the parafoveal capillaries, allowing leakage of the fluid and resultant 
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oedema. Occurrence of cystoid macular oedema (CME) is related to the 
synthesis of prostaglandins and other mediators.7, 8 Surgical trauma leads to 
release of prostaglandins, which causes a break in the blood- aqueous 
barrier,9 with resultant release of toxins and immune complexes (Fig 1). 
Prostaglandins pass through the vitreous into the posterior segment and 
result in outpouring of serous fluid into the Henle’s layer. Increased levels 
of prostaglandin E (PGE) and prostaglandin F2 (PGF2) have been 
demonstrated in patients with CME undergoing vitrectomy. Vitreous fibers 
are seen to course from the anterior vitreous to a set of holes in the 
posterior vitreous over the macular area and the optic nerve through which 
PGEs are thought to diffuse. The primary cause of CME is the leakage of 
fluid that is low in lipid and protein content from the perifoveal capillaries 
into the extra cellar spaces due to breakdown of the blood-aqueous 
barrier.10 
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Fig.1  Schematic representation of the etiopathogenesis of 
cystoid macular oedema 
 
   Surgical trauma 
   
Prostaglandins enter posterior segment        Prostaglandins released 
   
   Blood aqueous barrier breakdown 
occurs 
  
 Macular edema occurs  Immune complexes & toxins released 
 
  Inflammation occurs 
 
  Prostaglandins released 
 
Occurrence  of  CME  is related  to the synthesis  of prostaglandins and other  mediators. 
Surgical trauma leads to release  of prostaglandins which causes breakdown in  the  blood-
aqueous  barrier with resultant release of toxins and immune complexes. Prostaglandins pass 
through the vitreous into the posterior segment and result in outpouring of serous fluid in the 
Henle’s layer.   
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Risk factors 
 The following features have been identified as being risk factors for 
PCME namely:  
a) Age: Younger patients are more prone to develop PCME.11  
 b)  CME in the fellow eye: The incidence of clinically significant CME 
in the fellow eye when one eye has had this complication is reported to be 
as high as 50%.12 
c) Race: A lower incidence in blacks has been reported.12 
 d) Diabetes mellitus: Diabetics seem more prone to develop PCME. The 
incidence of clinical CME in diabetes is reported to be 9.3%, and its 
average period of presentation to be 3 to 6 months after surgery.13 
e) Systemic disorders: Patients with vascular diathesis, chronic 
alcoholism, rosacea and telangiectasia are reported to be at risk of 
developing PCME.11  
f) Epinephrine in infusion: It is not clear whether the use of epinephrine 
in the infusion fluid makes the eye prone to the development of PCME. 
g) Irrigation solution: Fluorophotometric evaluation of the blood- ocular 
barrier function following implant surgery reveals that physiological saline 
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produces more severe damage to the blood aqueous followed by Ringer 
lactate solution and balanced salt solution.14 
h) Exposure to microscope light: Increase exposure to microscope light 
and increase in the operating time. 
 
Preventive measures  
 Several measures have been described to prevent PCME, including;  
a)  Bag fixation of intraocular lens;15  
b)  Avoiding  posterior capsulotomy;  
c)  Use of ultraviolet (UV) filters16 and ultraviolet (UV) absorbing 
intraocular  lenses;17, 18  
d)  Minimizing exposure to the microscope light;19 
e)  Use of prophylactic steroids in high risk cases; 12, 20, 21 and   
f)  Minimizing operation time19   
 
 Although improved surgical techniques have decreased the 
incidence of PCME,  it remains a cause of unfavorable visual outcome 
following surgery ; moreover, there is a paucity of data related to changes 
in macular thickness following uneventful cataract surgery of different 
types. Fundus fluorescein angiography has been the gold standard for 
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diagnosis of subclinical PCME, but non-invasive cross-sectional imaging 
of the retina by OCT may also effectively detect the condition and has the 
added advantage of quantification and repeat results. Hence, in the present 
dissertation, an attempt has been made to study these aspects of PCME.   
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AIM OF THE STUDY 
 
1. To determine changes in macular thickness following uneventful 
cataract surgery. 
2. To elucidate the optical tomographic features of macular thickness 
after uneventful cataract surgery. 
3. To compare changes in macular thickness occurring following 
uneventful phacoemulsification and manual small incision cataract 
surgery. 
  
 
 
 
 
 
 
 
 9
REVIEW OF LITERATURE 
 
 Sourdille et al.22 evaluated macular thickness changes after 
uneventful cataract surgery using OCT and compared these with 
measurement of flare and cells of the anterior chamber. Forty-one eyes 
having  uneventful cataract surgery with clear corneal incision  with 
foldable intraocular  lens were evaluated by OCT and followed  at  1  ,8, 
12 , 30 and 60  days postoperatively. Clinical   and subclinical thickness 
changes without breakdown of the blood aqueous barrier could be detected 
after cataract surgery and most of these resolved spontaneously; this was 
not related to a higher quantum of postoperative flare. 
 
 Von  jogow  et al.23 used standardized OCT to find  subclinical 
changes in macular thickness postoperatively. Thirty-three patients without 
macular pathology in both eyes were examined; the contralateral eye 
served as control. All patients underwent phacoemulsification with 
intraocular lens (IOL) implantation. Axial length, anterior chamber depth, 
phaco time and phaco energy were noted. Postoperative macular thickness 
was measured at 1day, one week, and six weeks after surgery. Mean foveal 
thickness (MFT) was increased significantly at day one.  No clinical CME 
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was diagnosed in this study. After cataract surgery a mild increase of 
foveal thickness was noted which, however, did not impact visual acuity. 
Biometric parameters, such as phaco time, phaco energy and axial length, 
did not correlate with the degree of macular thickness.  
 
 Biro et al.24 found changes in foveal and perifoveal thickness after 
phacoemulsification and IOL implantation when OCT was used for 
measurement.  Seventy-one eyes underwent phacoemulsification with “in 
the bag” implantation of foldable IOL under topical anaesthesia. Data were 
collected one day before surgery and post- operatively on the first, 7th, 
30th and 60th day; the contralateral eye served as control. There were no 
significant changes in thickness at day one. However significant increases 
in thickness where detected, on the 7th , 30th and 60th  days, in the 
perifoveal 3.0 and 6.0 mm, either calculated alone or averaged together 
with the foveal values to provide a more accurate description of the 
postoperative macular oedema. Mild subclinical perifoveal oedema was 
detected using OCT at 7th postoperative day up to 6 months after surgery. 
OCT enables detection of minimal increases in perifoveal retinal thickness 
even 6 months after cataract surgery. 
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 Yazici et al.25 reported macular thickness changes after 
phacoemulsification combined with primary posterior curvilinear 
capsulorhexis. Forty patients under went phacoemulsification and ‘in the 
bag’ IOL implantation with primary posterior curvilinear capsulorhexis 
(PCCC) and without macular pathology before surgery. OCT was 
performed preoperatively and postoperatively on the 1st day, first week, 
and first, third and sixth months.  The greatest change in mean macular 
thickness was noted at the first month visit. No patient developed CME 
because PCCC does not have an adverse effect on macular integrity. 
Hence, this procedure may be performed in patients with a high risk of 
posterior capsular opacification. 
  
 Lobo et al.26 assessed macular alteration in 32 patients who 
underwent uneventful phacoemulsification with foldable IOL. 
Postoperatively patients were examined at the 3rd, 6th, 12th and 30th  weeks.  
The examination included retinal leakage analysis and OCT. Increase in 
retinal thickness reached a maximum at 6 weeks in 13 of 32 eyes after 
which recovery was progressive.  At 30 weeks, all eyes had good visual 
acuity, but 7 eyes still had macular odema.  Macular oedema after cataract 
surgery occurred primarily in the central region of the macula and was 
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associated with the presence of the leaking sites, which were 
predominantly in the vascular region of the central macula.  
 
 Nakayama et al.27 studied macular thickness after cataract surgery in 
diabetic patients. This study sought to evaluate the time course of change 
in macular thickness in diabetics compared with that of non-diabetic 
patients after uneventful cataract surgery.  Thirty-six diabetic and 30 non-
diabetic patients were examined preoperatively and postoperatively on the 
1st, 3rd, 7th, 30th , 90th and  180th  days.  Diabetics had prolonged and 
progressive macular thickening 6 months after surgery. Changes in 
non-diabetics improved gradually and returned to near normal within 6 
months. These authors found that retinal thickness analysis using the 
retinal thickness analyzer (RTA) is useful for early detection of macular 
oedema. These authors concluded that while cataract surgery induced 
subclinical macular oedema even in non-diabetic subjects, progressive 
macular edema might cause poor visual outcome in diabetic patients. 
 Jurecka et al.28 demonstrated macular thickness changes after 
uncomplicated cataract surgery measured by means of OCT to specify the 
incidence of CME. One hundred patients underwent uneventful 
phacoemulsification with “in the bag” IOL implantation. 
Phacoemulsification time and total duration of the surgery were noted. 
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OCT examination was performed preoperatively and postoperatively on 
the 1st day, at the 1stweek and during the 1st, 2nd, 3rd  and 6th months. The 
increase in the retinal thickness and macular volume reached the maximum 
in the 1st and 2nd month, and decreased after 3 months. There was a 
positive statistical correlation between the increase in retinal thickness and 
the real phacoemulsification time as well as between the increase in retinal 
thickness and the overall duration of the surgical procedure .The incidence 
of CME was 3%, but clinically significant CME was detected in 1% of the 
cases. Topical application of non-steroidal anti-inflammatory drugs 
effectively prevented the development of CME after an uneventful cataract 
surgery. 
 
 Sambuddha Ghosh et al.29 compared macular thickness following 
uncomplicated phacoemulsification with foldable acrylic lens and small 
incision cataract surgery (SICS) with non-foldable 
polymethylmethaacrylate lens. Two hundred and twenty-four patients 
underwent phacoemulsification and SICS by a simple1:1 randomization. 
Macular thickness was measured by OCT on the 1st,7th, 42nd, and 180th 
postoperative days. In spite of increased postoperative inflammation 
following SICS, there was no evidence of CME either clinically or on 
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OCT; however subclinical increase in macular thickness was greater 
following SICS compared to phacoemulsification. 
 
 15
MATERIALS AND METHODS 
 
 In the view of the variable results reported by investigators, an 
attempt has been made in the present dissertation to determine changes in 
macular thickness and to elucidate the OCT features of macula after 
uneventful cataract surgery performed by SICS and by 
phacoemulsification.  
 
 This study was performed at Joseph Eye Hospital, institute of 
ophthalmology, Trichy. 
 
 A total of fifty patients who underwent cataract surgery (28 males 
and 22 females), ranging in age from 35 to 78 (mean age 58.6 years) were 
enrolled in the study.   
  
 Inclusion criteria 
 Patients were enrolled in the study if they satisfied the following 
criteria: 
 a)   Cataract allowing pre operative OCT to be performed 
  b)  Patients without retinal or macular pathology 
 c)  Patients who underwent uneventful cataract surgery 
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Exclusion criteria 
 Patients were excluded from the study if the following were noted: 
a)  Mature cataract 
b)  Traumatic cataract 
c)  Complicated cataract  
d)  Complication during surgery. 
e)  Retinal pathology.  
 
Examination of patient  
 A complete ocular examination was done for all patients. 
Examination was done pre-operatively, per-operatively and post-
operatively.  
 
a)  Pre operative examination consisted of the following: 
1.  Determination of best corrected visual acuity by Snellen’s chart; 
2.  Slit lamp examination of the anterior segment; 
3.  Slit lamp biomicroscopy of the fundus using + 90D lens; 
4.  Fundus photography; and 
 5.  OCT fast macular scan, line scans through the fovea, retinal 
thickness analysis and retinal map analysis.
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Other routine examinations included determination of the:  
1. Intraocular pressure (IOP) by applanation tonometry; 
2.  Patency of the naso-lacrimal duct by syringing; 
3.  Axial length using the IOL master, and; 
4.  General examination 
 
b) Per- operative examination consisted of noting the following 
points:  
1.  Type of surgery, namely phacoemulsification or SICS; 
2.  Total duration of the surgery, and the actual phacoemulsification 
time; and  
3.  Absence of surgical complications.  
 
c) Post - operative examination included the following: 
1.  Determination of the best corrected visual acuity;   
2.  Slit lamp examination of the anterior segment; 
3.  Slit lamp biomicroscopy of the fundus using +90D lens; 
4.  Fundus photography; and 
5.  OCT macular scan. 
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Surgical technique 
 Patients underwent Phacoemulsification using a 2.8 mm superior or 
superotemporal scleral tunnel incision with a divide and conquer 
technique. A foldable acrylic intraocular lens was inserted in the capsular 
bag at the end of surgery. 
 
 Patients underwent manual small incision cataract surgery using a 
6.0 or 6.5 mm superior or superotemporal scleral tunnel incision. Nucleus 
was removed using the sandwich technique. A 6.0 mm PMMA single piece 
rigid intraocular lens was implanted in the bag at the end of surgery. 
 
 Follow up of the patients was done at one, two and four weeks after 
the surgery and also three months after surgery.   
 
Examination of the patient’s eyes by OCT 
  Each  eye  of  each  subject  was  dilated  with  1%  tropicamide 
and  5%  phenylephrine   hydrochloride  before  recording  the  image. The 
patient was seated comfortably in front of the OCT machine (Zeiss Stratus 
3) with chin positioned on the chin rest, and was asked to fixate on the 
fixation target. The internal fixation (green colour light) target was the 
commonly used fixation target. After fixation, the operator selected the 
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desired scan (Raster line scan with length of 5 mm in horizontal and 
vertical axis; Fast macular scan protocol) and aligned the instrument so 
that the fundus image and scan beam were displayed on the screen. In 
patients with significant refractive errors, rotation of the dioptre 
compensation device was found to improve image quality. Retinal 
thickness was  quantitated  by the computer  for  each  scan  in  the  image 
as  the distance  between   the  first  reflection  at  the  vitreoretinal 
interface  and  the  anterior boundary  of  the  red,  reflective  layer 
corresponding  to  the  retinal  pigment epithelium  and  choriocapillaries.  
Besides retinal thickness, retinal architecture with presence of any retinal 
edema, cystoid spaces, hard exudates and sub-retinal fluid were 
specifically looked for. 
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Picture showing line scan protocol 
 
 
Picture showing Fast macular scanning 
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Interpretation of the OCT scans 
 The reflectivity pattern of the scanned images was studied. 
a)  Hyperreflectivity patterns: suggested the following:  
1)  Hard exudates;  
2)  Hyperreflective shadows in the neurosensory retina that 
completely blocked the reflections from the underlying retina. 
 
Blood: If a thin layer, this was hyperreflective whereas a thick layer was 
found to block the underlying reflections and 
3)  Scar tissue and neovascular membranes (showed varying 
Hyperreflectivity);  
 
b)  Hyporeflective patterns were presumed to suggest the following: 
1)  Serous fluid;  
2)  Optically empty space with absence of backscattering; and  
3)  Cystoid spaces in the retina. 
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RESULTS 
 
 This study was conducted at a tertiary eye care hospital in 
Tiruchirapalli, Tamilnadu over a period of 12 months (from August 2010 
to August 2011). Based on the defined inclusion and exclusion criteria, 50 
individuals (28 [56%] males and 22[54%] females were enrolled in the 
study. The age of the patients (Fig. 2a) ranged from 35 to 78 years [mean 
age 58.36 ±10.23 years {95% confidence interval (C.I.) = 55.45 to 61.27 
years}]. Of these, 25 (50% of total) individuals underwent small incision 
cataract surgery (SICS) in one eye with “in the bag” polymethacrylate 
intraocular lens (PMMA IOL) implantation, while the other 25 (50% of 
total) individuals underwent phacoemulsification in one eye with “in the 
bag” acrylic type of foldable IOL. The surgeries on these individuals were 
performed by three experienced surgeons.  
 
1.  Age of patients  
 The mean age of the 25 patients who underwent the SICS procedure 
was 57.04 ± 8.05 [95% C.I.= 53.72 to 60.36] years (Fig. 2b) while the 
mean age of the 25 patients who underwent the phacoemulsification 
procedure was 59.68 ± 12.05 [95 % C.I.= 54.71 to 64.65] years (Fig. 2c); 
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this difference was not statistically significant (`t’ test [degree of freedom 
{d.f.}=48] =  0.9110 ; P = 0.37).  
 
2.  Gender of the patients  
 In the SICS group, there were 10 males and 15 females while in the 
phacoemulsification group, there were 12 males and 13 females; this 
difference was not statistically significant (λ2 (d.f.=1)= 0.38; P > 0.05)  
(Fig. 3).  
 
3.  Conditions associated with cataract in the patients and laterality 
of the operated eye 
 Forty-three (86 %) of the 50 patients did not have any systemic 
illness. Seven (14%) of the 50 patients suffered from hypertension; one of 
these hypertensive patients underwent SICs while the other six 
hypertensive patients underwent phacoemulsification.  
 
 The right eye was operated on in 25 of the 50 patients while the left 
eye was operated on in the other 25 patients. In the SICs group, the right 
eye was operated on in 11 patients and the left eye was operated on in 14 
patients, while in the phacoemulsification group, the right eye was 
operated on in 14 patients and the left eye was operated on in 11 patients; 
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this difference was not statistically significant (λ2 (d.f.=1)= 0.72; P > 0.05) 
(Fig. 4).  
 
4.  Duration of ocular surgery in the two groups of patients 
 Overall, in the 50 patients, the mean surgical time was 10.16 ± 1.04 
(95 % C.I. =9.87 to 10.45) minutes (Fig. 5a) . In the 25 patients who 
underwent SICS, the mean surgical time was 10.0 ± 0.87 ( 95 % C.I.= 9.64 
to 10.36) minutes (Fig. 5b), which was less than the mean surgical time 
(10.32 ± 1.18 [95 % C.I. = 9.83 to 10.81])  minutes  in the 25 patients who 
underwent phacoemulsification (Fig. 5c); however, this difference was not 
statistically significant (`t’ [d.f.= 48]= 1.09 ; P=0.28)  . In the 25 patients 
who underwent phacoemulsification, the mean phacoemulsification time 
was 1.28 ± 0.4 minutes (Fig. 5d).  
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5.  Visual acuity in the operated eyes of patients who underwent 
cataract surgery 
 In the 50 patients, the mean pre–operative visual acuity was 0.31 ± 
0.2 (95 % C.I. = 0.26 to 0.36) decimals (approximately 6/18p) while the 
mean post-operative visual acuity was 0.68 ± 0.2 (95 % C.I. = 0.63 to 0.72) 
decimals (approximately 6/9) (Fig. 6a); this difference was statistically 
significant (`t’ [d.f.= 98]= 9.25 ; P <0.0001).  
 
 In the 25 patients who underwent SICS, the mean pre-operative 
visual acuity was 0.21 ± 0.15 (95 % C.I. = 0.15 to 0.27) decimals 
(approximately 6/36p) while the mean postoperative visual acuity was 0.65 
± 0.17 (95 % C.I. = 0.59 to 0.72) decimals (approximately 6/9) (Fig. 6b); 
this difference was statistically significant (“t” [d.f.=48]=9.9  ; P <0.0001). 
In the 25 patients who underwent phacoemulsification cataract surgery, the 
mean pre-operative visual acuity was 0.40 ± 0.17 (95 % C.I. = 0.33 to 
0.47) decimals (approximately 6/18) while the mean postoperative visual 
acuity was 0.70 ± 0.17 (95 % C.I. = 0.63 to 0.77) decimals (approximately 
6/6p) (Fig. 6c); this difference was statistically significant (“t” [d.f.=48]= 
6.27 ; P < 0.0001).  
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  Interestingly, the mean pre-operative visual acuity was 0.21 ± 0.15 
(95 % C.I. = 0.15 to 0.27) decimals in the 25 patients who underwent SICS 
and was 0.40 ± 0.17 (95 % C.I. = 0.33 to 0.47) decimals in the 25 patients 
who underwent phacoemulsification; this difference was statistically 
significant (`t’ [d.f.=48]= 4.20; P=0.0001). However, the difference 
between the mean post-operative visual acuity in the patients who 
underwent SICS (0.65 ± 0.17 [95 % C.I. = 0.59 to 0.72] decimals) and the 
mean post-operative visual acuity in the patients who underwent 
phacoemulsification (0.70 ± 0.17 [95 %  C.I. = 0.63 to 0.77] decimals) was 
not statistically significant (`t’[d.f.=48]= 0.98; P=0.33).  
 
6.  Macular thickness in the operated eyes of patients who 
underwent cataract surgery 
 In the 50 patients who underwent cataract surgery, the pre-operative 
macular thickness noted was 172±27µ. The mean pre-operative macular 
thickness was 162.66 ± 14.53 (95% C.I.=158.53 to 166.79) µ (Fig. 7a). 
Post- operatively, the following readings were noted:  
 
a)  at the first week review, the macular  thickness was 183±31 µ and 
the mean macular thickness was 173.26 µ ± 13.51(95% C.I.=169.42 
to 177.10) µ;  
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b)  at the second week review, the macular thickness was 178±23µ and 
the mean macular thickness was 171.82µ ± 12.86 (95 % 
C.I.=168.17 to 175.47) µ;  
c)  at the fourth  week review, the macular  thickness was 184 ± 32µ 
and the mean macular thickness was 168.68 µ ± 14.41(95% 
C.I.=164.59 to 172.77) µ;  
d)  at the third month  review, the macular  thickness was 184±31 µ and 
the mean macular thickness was 166.12 ± 13.85(95% C.I.=162.19 
to 170.05) µ (Fig. 7a). 
 
 Statistical analysis of the differences between the 5 mean values 
(pre-operative, postoperative 1st, 2nd and 4th weeks and post-operative 3rd 
month) was done by one-way analysis of variance (ANOVA); the 
differences were found to be statistically significant (Fisher `f’ value= 
4.792; P=0.001). Post-hoc testing was then done by Tukey’s method to 
determine the significance of intergroup differences. Highly significant 
(P<0.01) or significant (P<0.05) differences  were noted between the 
preoperative mean value and the post-operative 1st week mean value , 
preoperative mean value and the post-operative 2ndt week mean value, and 
the preoperative mean value and the post-operative 4th week mean value, 
between the post-operative 1st week mean value and the post-operative 3rd 
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month mean value, and the post-operative 2nd week mean value and the 
post-operative 3rd month mean value of macular thickness. 
 
 In the 50 patients who underwent cataract surgery, subclinical 
macular oedema was noted at the first, second and fourth week reviews; 
the peak subclinical macular odema was noted at the first week review. 
However, at the third month review, the macular edema had reduced (Fig. 
7b). 
 
 The baseline (preoperative) macular thickness noted in the 25 
patients who underwent SICS was 163±20µ while the mean thickness was 
160.68µ ± 10.78 (95% C.I.= 156.23 to 165.13) (Fig. 8a). Post-operatively, 
the following readings were noted:  
 
a)  at the first week review, the macular  thickness was 175±18µ  and 
the mean macular thickness was 171.2 µ ± 10.63(95% C.I.=166.81 
to 175.59) µ;  
b)  at the second week review, the macular thickness was 170 ± 15 µ 
and the mean  macular thickness was 170.48 µ ± 11.2 (95 % 
C.I.=165.86 to 175.10) µ;  
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c)  at the fourth  week review, the macular  thickness was 180 ± 30µ 
and the mean macular thickness was 167.4 µ ± 15.02 (95% 
C.I.=161.2  to 173.6) µ;  
d)  at the third month  review, the macular  thickness was 180±30 µ and 
the mean macular  thickness was 165.64 ± 15.01 (95% C.I.=159.44 
to 171.84) µ (Fig. 8a). 
 
 Statistical analysis of the differences between the 5 mean values 
(pre-operative, postoperative 1st, 2nd and 4th weeks and post-operative 3rd 
month ) in the patients who had undergone SICS was done by one-way 
ANOVA; the differences were found to be statistically significant (Fisher 
`f’ value= 2.780; P=0.03). Post-hoc testing was then done by Tukey’s 
method to determine the significance of intergroup differences. Highly 
significant (P<0.01) or significant (P<0.05) differences  were noted 
between the preoperative mean value and the post-operative 1st week mean 
value , preoperative mean value and the post-operative 2nd week mean 
value, and the  preoperative mean value and the post-operative 4th week 
mean value of macular thickness.  
 
 In the 25 patients who underwent SICS, subclinical macular edema 
was noted at the first, second and fourth week reviews. (Fig. 8b)  
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 In the 25 patients who underwent phacoemulsification, the pre-
operative macular    thickness was 172±32µ while the mean value was 
164.64 ± 17.51 (95 % C.I. = 157.41 to 171.87) µ. Post-operatively, the 
following readings were noted: 
 
a)  at the first week review, the macular  thickness was 182 ± 32 µ and 
the mean macular thickness was 175.32µ ± 15.84 (95% 
C.I.=168.78  to 181.86) µ;  
b)  at the second week review, the macular thickness was 175±25µ and 
the mean macular   thickness was 173.16µ ± 14.44  (95 % 
C.I.=167.72  to 179.12) µ;  
 c)  at the fourth  week review, the macular  thickness was 172±20µ  and 
the  mean macular thickness was  169.96µ ±  13.95  (95% 
C.I.=164.2 to 175.72) µ;  
d)  at the third month  review, the macular  thickness was 169 ± 24 µ 
and the mean macular thickness was 166.6 ± 12.86 (95% 
C.I.=161.29 to 171.91) µ (Fig. 9a). 
 
 Statistical analysis of the differences between the 5 mean values 
(pre-operative, postoperative 1st, 2nd and 4th weeks and post-operative 3rd 
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month ) in the patients who had undergone phacoemulsification was done 
by one-way ANOVA; the differences were not found to be statistically 
significant (Fisher `f’ value= 2.18; P=0.075). Post-hoc testing was then 
done by Tukey’s method to determine the significance of intergroup 
differences Significant (P<0.05) differences  were noted between the 
preoperative mean value and the post-operative 1st week mean value , 
preoperative mean value and the post-operative 2nd week mean value, and 
the  postoperative 1st week mean value and the  post-operative 4th week 
mean value of macular thickness.  
  
 In the 25 patients who underwent phacoemulsification, there was a 
significant subclinical change in the macular thickness at the first and 
second week follow up (Fig. 9b) without, the visual acuity being affected.  
  
 When both the groups (patients who had undergone SICS and those 
who had undergone phacoemulsification cataract surgery were compared, a 
prolonged subclinical macular oedema was noted up to the fourth week 
review in the SICS group whereas in the patients who had undergone 
phacoemulsification, the macular thickness was found to be increased up to 
the second week review (Fig. 10),(Fig.11a and b) However, differences 
between the two groups in the mean macular thickness values noted 
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preoperatively (`t’ (d.f.=48)= 0.96; P>0.05) and at 1 week(`t’ (d.f.=48)= 
1.06; P>0.05), 2 weeks(`t’ (d.f.=48)= 0.73; P>0.05), 4 weeks(`t’ (d.f.=48)= 
0.62; P>0.05) and 3 months (`t’ (d.f.=48)= 0.24; P>0.05)postoperatively 
were not statistically significant  
  
 Cystoid macular edema was not noted in any of the patients in the 
current study.  
 
 
 
 
 
 33
 
 
 
 
 
Figure 2a. Age (in years) of the 50 individuals enrolled in the study  
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Figure 2b. Age (in years) of the 25 individuals who underwent small 
incision cataract surgery  
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Figure 2c. Age (in years) of the 25 individuals who underwent 
phacoemulsification cataract surgery  
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Figure  3. Gender distribution of the individuals enrolled in the study 
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Figure  4. Laterality of the eye operated in the different surgeries 
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Figure 5a.  Duration of surgery (surgical time) in 50 patients who 
underwent  cataract surgery 
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Figure 5b.  Duration of surgery (surgical time) in 25 patients who 
underwent  small incision cataract surgery (SICS) 
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Figure 5c.  Duration of surgery (surgical time) in 25 patients who 
underwent  phacoemulsification cataract surgery 
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Figure 5d.  Duration of phacoemulsification (phaco time) in 25 
patients who underwent phacoemulsification cataract 
surgery 
 
 
 
 
 
 
 
 
 42
 
 
 
 
Figure 6a.  Pre-operative and post-operative visual acuity in 50 
patients who underwent cataract surgery 
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Figure 6b. Pre-operative and post-operative visual acuity in 25 
patients who  underwent small incision cataract surgery 
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Figure 6c.  Pre-operative and post-operative visual acuity in 25 
patients who underwent phacoemulsification cataract 
surgery 
 
 
 
 
 
 
 
 45
 
 
 
 
 
 
 
 
Figure 7a.  Preoperative and post-operative macular thickness in 50 
patients who underwent cataract surgery 
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Figure 7b.  Preoperative and post-operative mean macular thickness 
in 50 patients who underwent cataract surgery 
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Figure 8a.  Preoperative and post-operative macular thickness in 25 
patients who underwent small incision cataract surgery 
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Figure 8b.  Preoperative and postoperative mean macular thickness 
in 25 patients who underwent small incision cataract 
surgery 
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Figure 9a.  Preoperative and post-operative macular thickness in 25 
patients who underwent phacoemulsification cataract 
surgery 
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Figure 9b.  Preoperative and post-operative mean macular thickness 
in 25 patients who underwent phacoemulsification  
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Figure 10.  A comparison of preoperative and postoperative mean 
macular thickness in patients who underwent small 
incision cataract surgery and patients who underwent 
phacoemulsification cataract surgery  
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Figure 11a.  OCT picture shows the preoperative macular area with 
thickness of 152 microns. 
 
 
 
 
 
Figure 11b. OCT picture shows the postoperative subclinical macular 
edema with thickness of 184 microns. 
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DISCUSSION 
 
 Following cataract surgery, subclinical changes may occur in 
macular thickness without the visual acuity being affected. However, 
pseudophakic cystoid macular edema (PCME) is a known complication of 
cataract and intraocular lens (IOL) surgery, manifesting as effusion of fluid 
from the capillaries. Although this phenomenon is most often self-limiting, 
culminating in spontaneous resolution, it occasionally leads to marked 
impairment of central vision, which may become chronic or permanent. In 
the present investigation, on which this dissertation is based, an attempt 
was made to determine putative alterations in best corrected visual acuity 
(BCVA) and macular thickness in two groups of patients, namely, those 
undergoing small incision cataract surgeries (SICS) and those undergoing 
phacoemulsification cataract surgery.  
 
 Sambuddha Ghosh et al.29 performed a prospective, randomized 
comparative study of macular thickness following phacoemulsification 
cataract surgery and that following SICs.  The mean age of the patients 
was 62 ± 6 years and 61 ± 6 years in the SICS and phacoemulsification 
groups, respectively. Males accounted for 58% of patients in the SICS 
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group and for 53.5% of patients in the phacoemulsification group. There 
was no significant difference in age or gender between the two groups. The 
right eye was operated on in 49.1% of patients in the SICS group and in 
50.9% of patients in the phacoemulsification group, the difference not 
being statistically significant29. 
 
 In the present investigation, results similar to those of Ghosh et al29 
were noted. The mean age of the 25 patients who underwent the SICS 
procedure was  57.04 ± 8.05 [95% C.I.= 53.72 to 60.36] years while the 
mean age of the patients who underwent the phacoemulsification 
procedure was 59.68 ± 12.05 [95 % C.I.= 54.71 to 64.65] years ; this 
difference was not statistically significant (`t’ test [degree of freedom 
{d.f.}=48] =  0.9110 ; P = 0.37). In the SICS group, there were 10 males 
and 15 females while in the phacoemulsification group, there were 12 
males and 13 females; this difference was also not statistically significant 
(λ2 (d.f.=1)= 0.38; P > 0.05).The right eye was operated on in 25 of the 50 
patients while the left eye was operated on in the other 25 patients. In the 
SICs group, the right eye was operated on in 11 patients and the left eye 
was operated on in 14 patients, while in the phacoemulsification group, the 
right eye was operated on in 14 patients and the left eye was operated on in 
11 patients; this difference was not statistically significant (λ2 (d.f.=1)= 
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0.72; P > 0.05). The present study, as well as the study by Ghosh et al.29, 
appear hitherto to be the only studies that have compared macular 
thickness changes after uneventful SICS and phacoemulsification cataract 
surgery.  
 
 Nakayama et al27. reported that , following cataract surgery, macular 
thickening and an increase in aqueous flare and cells were marked in 
diabetic eyes  In non diabetic patients, these subtle changes improved 
gradually and returned to near normal within 6 months; however, in 
diabetic patients , prolonged and progressive macular thickening was 
observed 6 months after surgery with decreased visual acuity due to 
macular oedema. Considering these possible confounding factors, in the 
present investigation, diabetic patients were excluded from the study.  This 
is one of the original aspects of the present investigation.  
 
 In the present study, 43 (86 %) of the 50 patients did not have any 
systemic illness. Seven (14%) of the 50 patients suffered from 
hypertension; one of these hypertensive patients underwent SICs while the 
other six hypertensive patients underwent phacoemulsification. 
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 Jurecka et al28 noted that there was a positive statistical correlation 
between the real phacoemulsification time and the increase in macular 
volume and retinal thickness in the fovea and the inner macular area in the 
first week and in the first and second months following surgery). 
Moreover, a positive statistical correlation was found between the overall 
duration of the surgical procedure and the increase in the macular volume 
and retinal thickness in all areas one month after surgery  
 
 In the present investigation, overall in the 50 patients, the mean 
surgical time was 10.16 ± 1.04 (95 % C.I. =9.87 to 10.45) minutes. In the 
25 patients who underwent SICS, the mean surgical time was 10.0 ± 0.87 ( 
95 % C.I.= 9.64 to 10.36) minutes , which was less than the mean surgical 
time (10.32 ± 1.18 [95 % C.I. = 9.83 to 10.81])  minutes  in the 25 patients 
who underwent phacoemulsification ; however, this difference was not 
statistically significant (`t’ [d.f.= 48]= 1.09 ; P=0.28)  . In the 25 patients 
who underwent phacoemulsification, the mean phacoemulsification time 
was 1.28 ± 0.4 minutes. In the present study, there was no positive 
correlation between the increase in retinal thickness and the real 
phacoemulsification time, or between the increase in retinal thickness and 
the overall duration of the surgical procedure. 
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 Von Jagow et al23. Found no correlation between macular thickening 
and visual acuity and selected surgical and biometrical parameters. 
Surgical and biometric parameters, such as phacoemulsification time and 
energy and axial length, did not correlate with the degree of macular 
thickness. In the present investigation also, the phacoemulsification time, 
energy and axial length did not correlate with changes in the macular 
thickness.  
 
 In studies by Gogate et al30; Ruit et al31 and Sambuddha Ghosh et 
al29. the visual outcome was identical with the six month follow up. In the 
current study, the visual acuity was identical in all the reviews, up to the 
third month.  
 
 In the studies by Polito et al32 and Danis et al33, the `fast macular 
thickness’ map protocol was used widely in measuring the macular 
thickness, which provided good repeatability and reproducibility.  In the 
present investigation, , the `fast macular thickness’ map protocol was used 
for measuring macular thickness. 
 
 In the study by Sambuddha Ghosh et al29, the first post-operative day 
macular thickness was used as the baseline macular thickness value. 
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However, in the present investigation, the pre- operative macular thickness 
reading was considered to be the baseline value. 
 
 Sourdille et al22. Evaluated changes in macular thickness following 
uneventful cataract surgery by using OCT, and compared the OCT findings 
with those of flare and cells. Although some postoperative increase in 
macular thickness was noted in 11 eyes, this was not related to a higher 
postoperative flare; moreover, visual consequences were proportionate to 
the macular thickness. In the present investigation,  patients with a high 
level of flare and with corneal edema were excluded from the study.  
 
 Brio et al24. Studied changes in foveal and perifoveal thickness as 
determined by OCT; after phacoemulsification cataract surgery with IOL 
implantation. These authors noted a significant change in the macular 
thickness on post operative days 1, 30, and 60, in the perifoveal 3.0 and 6.0 
mm sectors, either calculated alone or averaged together with the foveal 
values. The initial preoperative mean value of 234.1± 2.6 microns (mean ± 
SEM, n=536) in the 6.0mm perifoveal region increased to 242.5±2.6 
microns (mean± SEM, n=488,p=<0.05) at one week, to 247.7±4.6 microns 
(n=352, p<0.01) at one month, and to 246.0± 5.9 microns (n=208, p<0.05) 
at two months after surgery, which proved to be significant.  However, the 
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relative change in the macular thickness, namely 3.5, 5.6, and 5.3% at the 
above periods, respectively, was moderate.  
 
 In the current study, similar changes were noted in the 
phacoemulsification cataract surgery group (25 patients). The pre-
operative macular thickness was 172±32µ while the mean value was 
164.64 ± 17.51 (95 % C.I. = 157.41 to 171.87) µ. At the first week review, 
the macular  thickness had increased to 182 ± 32 µ , with a mean macular 
thickness of 175.32µ ± 15.84 (95% C.I.=168.78  to 181.86) µ. At the  
second week review, the macular thickness was 175±25µ and the mean 
macular  thickness was 173.16µ ± 14.44  (95 % C.I.=167.72  to 179.12) 
µ, while at the fourth  week review, the macular  thickness was 172±20µ 
and the  mean macular thickness was  169.96µ ±  13.95  (95% C.I.=164.2 
to 175.72) µ. At the final review (third month post-surgery), the macular 
thickness was 169 ± 24 µ and the mean macular thickness was 166.6 ± 
12.86 (95% C.I.=161.29 to 171.91) µ. When differences between these five 
mean values were subjected to statistical analysis by one-way ANOVA, 
they were found not statistically significant. When post-hoc testing was 
done, significant (P<0.05) differences  were noted between the 
preoperative mean value and the post-operative 1st week mean value , 
preoperative mean value and the post-operative 2nd week mean value, and 
the  postoperative 1st week mean value and the  post-operative 4th week 
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mean value of macular thickness. In the 25 patients who underwent 
phacoemulsification in the present investigation, there was a significant 
subclinical change in the macular thickness at the first week follow- up 
without, however, the visual acuity being affected.  
 
 Sambuddha Ghosh et al.29 performed a prospective randomized 
comparative study of macular thickness following phacoemulsification 
cataract surgery and that following SICS. On the first postoperative day, 
the central subfield mean thickness (CSMT) in the SICS group (192.8 ± 
17.9 µm) was not significantly different from that in the 
phacoemulsification group (192.1 ± 27.4 µm). However, on the 7th day, 
the CSMT in the SICS group (198.9 ± 21.4µm) was significantly greater 
than that in the phacoemulsification group (193.1 ±19.3µm). Again, on the 
42nd day, the CSMT in the SICS group (207.8± 26.3 µm) significantly 
exceeded that in the phacoemulsification group (198.3 ± 23µm). The 
increase in macular thickness was sub-clinical and did not affect final 
visual outcome in any patient.  
 
 In the present investigation, findings that were similar to those of 
Ghosh et al. were noted. When both the groups (patients who had 
undergone SICS and those who had undergone phacoemulsification 
cataract surgery) were compared, a prolonged subclinical macular oedema 
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was noted up to the fourth week review in the SICS group whereas in the 
patients who had undergone phacoemulsification, the macular thickness 
was found to be increased up to the second week review. However, 
differences between the two groups in the mean macular thickness values 
noted preoperatively and at 1 week, 2 weeks, 4 weeks and 3 months 
postoperatively were not statistically significant 
 
 Mentes et al34, Biro et al24 and Sambuddha Ghosh et al29 did not 
observe clinical macular odema in their study population. Similarly, in the 
present study, cystoid macular edema was not noted in any of the patients.  
 
 One of the limitations of the present study was the relatively short 
post-operative duration over which patients came for review. An important 
reason for this was that, in the absence of notable complications, patients 
felt it was not necessary to present for review. It is possible that if the 
follow-up period had been longer, the results may have been different. 
Another limitation of the study is that the number of patients ultimately 
enrolled in the two study groups were less than that calculated for the 
sample size. Future studies are required to confirm the initial results of the 
present investigation. In these future studies, a larger number of patients 
should be enrolled and the study period should be extended.  
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CONCLUSIONS 
 
• Subclinical macular edema occurs after uncomplicated cataract surgery 
with a peak at 1 week after surgery and can last for up to 4 weeks. 
• OCT showed macular edema without altering the architecture of the 
macula.   
• The duration of the subclinical edema is longer in eyes undergoing 
manual SICS as compared to those undergoing phacoemulsification.  
• There is no effect of this edema on visual acuity. 
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SUMMARY 
 
 Following cataract surgery, subclinical changes may occur in 
macular thickness without the visual acuity being affected. Although 
pseudophakic cystoid macular edema (PCME) may occur, this is most 
often self-limiting, culminating in spontaneous resolution, although there is 
occasionally marked impairment of central vision. In the present 
investigation, conducted at a tertiary eye care facility in southern India 
over a period of 12 months, an attempt was made to determine putative 
alterations in best corrected visual acuity (BCVA) and macular thickness 
in two groups of patients, namely, those undergoing small incision cataract 
surgeries (SICS) and those undergoing phacoemulsification cataract 
surgery.  
 Based on defined inclusion and exclusion criteria, 50 
individuals (28 [56%] males and 22[54%] females) were enrolled in the 
study. Of these, 25 (50% of total) individuals underwent SICS in one eye 
with “in the bag” polymethacrylate intraocular lens (PMMA IOL) 
implantation, while the other 25 (50% of total) individuals underwent 
phacoemulsification in one eye with “in the bag” acrylic type of foldable 
IOL. The mean age of the 25 patients who underwent the SICS procedure 
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(57.04 ± 8.05 years) was not significantly different from that of the 25 
patients who underwent the phacoemulsification procedure (59.68 ± 12.05 
years). In the SICS group, there were 10 males and 15 females while in the 
phacoemulsification group, there were 12 males and 13 females (difference 
not statistically significant).  
 
 Forty-three (86 %) of the 50 patients did not have any systemic 
illness. Seven (14%) of the 50 patients suffered from hypertension; one of 
these hypertensive patients underwent SICS while the other six 
hypertensive patients underwent phacoemulsification.  The right eye was 
operated on in 25 of the 50 patients while the left eye was operated on in 
the other 25 patients. In the SICs group, the right eye was operated on in 
11 patients and the left eye was operated on in 14 patients, while in the 
phacoemulsification group, the right eye was operated on in 14 patients 
and the left eye was operated on in 11 patients; this difference was not 
statistically significant.  
 
 Overall, in the 50 patients, the mean surgical time was 10.16 ± 1.04 
minutes. In the 25 patients who underwent SICS, the mean surgical time 
was 10.0 ± 0.87  minutes  which was not significantly different from the 
mean surgical time (10.32 ± 1.18 minutes)  in the 25 patients who 
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underwent phacoemulsification  In the 25 patients who underwent 
phacoemulsification, the mean phacoemulsification time was 1.28 ± 0.4 
minutes.  
 
 In the 50 patients, the mean pre–operative visual acuity was 0.31 ± 
0.2 decimals (approximately 6/18p), which showed a significant 
improvement following surgery to a mean value of 0.68 ± 0.2 decimals 
(approximately 6/9). Similarly, in the 25 patients who underwent SICS, the 
mean pre-operative visual acuity (0.21 ± 0.15  decimals [approximately 
6/36p]) showed a significant improvement following surgery to a mean 
value of 0.65 ± 0.17  decimals (approximately 6/9)  while in the 25 patients 
who underwent phacoemulsification cataract surgery, the mean pre-
operative visual acuity (0.40 ± 0.17 decimals) also exhibited a significant 
improvement to a mean postoperative visual acuity of 0.70 ± 0.17 
decimals (approximately 6/6p).  
 
 Interestingly, the mean pre-operative visual acuity (0.21 ± 0.15 
decimals) in the 25 patients who underwent SICS was significantly less 
than that (0.40 ± 0.17 decimals) in the 25 patients who underwent 
phacoemulsification whereas there was no significant difference between 
the two groups in the mean post-operative visual acuity.  
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 In the 50 patients who underwent cataract surgery, the pre-operative 
macular thickness noted was 172±27µ. The mean pre-operative macular 
thickness was 162.66 ± 14.53 while post- operatively at the first week 
review, the macular  thickness was found to have increased to 183±31 µ, 
with a mean value of 173.26 µ ± 13.51 µ; at the second week review, the 
macular thickness was 178±23µ and the mean macular thickness was 
171.82µ ± 12.86  µ; at the fourth  week review, the macular  thickness was 
184 ± 32µ  and the mean macular thickness was 168.68 µ ± 14.41µ; at the 
third month  review, the macular  thickness was 184±31 µ and the mean 
macular thickness was 166.12 ± 13.85 µ.  
 
 Statistical analysis revealed that the differences between these five 
mean values were significant. Highly significant (P<0.01) or significant 
(P<0.05) differences  were noted between the preoperative mean value and 
the post-operative 1st week mean value , preoperative mean value and the 
post-operative 2ndt week mean value, and the  preoperative mean value 
and the post-operative 4th week mean value, between the post-operative 1st 
week mean value and the post-operative 3rd month mean value, and the 
post-operative 2nd week mean value and the post-operative 3rd month mean 
value of macular thickness. In the 50 patients, subclinical macular oedema 
was noted at the first, second and fourth week reviews; while the peak 
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subclinical macular odema was noted at the first week review, at the third 
month review, the macular edema had reduced  
 
 The baseline (preoperative) macular thickness noted in the 25 
patients who underwent SICS was 163±20µ while the mean thickness was 
160.68µ ± 10.78 a).  At the post-operative first week review, the macular 
thickness was 175±18µ  and the mean macular thickness was 171.2 µ ± 
10.63; at the post-operative second week review, the macular thickness 
was 170 ± 15 µ and the mean macular thickness was 170.48 µ ± 11.2  µ; 
at the post-operative fourth  week review, the macular  thickness was 180 
± 30µ  and the mean macular thickness was 167.4 µ ± 15.02 µ; at the post-
operative third month  review, the macular  thickness was 180 ± 30 µ and 
the mean macular  thickness was 165.64 ± 15.01 µ. Statistical analysis 
(one-way ANOVA) of the differences between these 5 mean values 
revealed significant differences. Post-hoc testing revealed highly 
significant (P<0.01) or significant (P<0.05) differences  between the 
preoperative mean value and the post-operative 1st week mean value , 
preoperative mean value and the post-operative 2nd week mean value, and 
the  preoperative mean value and the post-operative 4th week mean value 
of macular thickness. In the 25 patients who underwent SICS, subclinical 
macular edema was noted at the first, second and fourth week reviews.  
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 In the 25 patients who underwent phacoemulsification cataract 
surgery, the pre-operative macular thickness was 172±32µ while the mean 
value was 164.64 ± 17.51 (95 % C.I. = 157.41 to 171.87) µ. At the first 
week review, the macular  thickness had increased to 182 ± 32 µ , with a 
mean macular thickness of 175.32µ ± 15.84 (95% C.I.=168.78  to 181.86) 
µ. At the  second week review, the macular thickness was 175±25µ and the 
mean macular  thickness was 173.16µ ± 14.44  (95 % C.I.=167.72  to 
179.12) µ, while at the fourth  week review, the macular  thickness was 
172±20µ  and the  mean macular thickness was  169.96µ ±  13.95  (95% 
C.I.=164.2 to 175.72) µ. At the final review (third month post-surgery), the 
macular thickness was 169 ± 24 µ and the mean macular thickness was 
166.6 ± 12.86 (95% C.I.=161.29 to 171.91) µ. When differences between 
these five mean values were subjected to statistical analysis by one-way 
ANOVA, they were found not statistically significant. When post-hoc 
testing was done, significant (P<0.05) differences  were noted between the 
preoperative mean value and the post-operative 1st week mean value , 
preoperative mean value and the post-operative 2nd week mean value, and 
the  postoperative 1st week mean value and the  post-operative 4th week 
mean value of macular thickness. In the 25 patients who underwent 
phacoemulsification in the present investigation, there was a significant 
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subclinical change in the macular thickness at the first week follow- up 
without, however, the visual acuity being affected.  
 
 When both the groups (patients who had undergone SICS and those 
who had undergone phacoemulsification cataract surgery) were compared, 
a prolonged subclinical macular oedema was noted up to the fourth week 
review in the SICS group whereas in the patients who had undergone 
phacoemulsification, the macular thickness was found to be increased up to 
the second week review.  However, differences between the two groups in 
the mean macular thickness values noted preoperatively and at 1 week, 2 
weeks, 4 weeks and 3 months postoperatively were not statistically 
significant. 
 
 Cystoid macular edema was not noted in any of the patients in the 
current study. 
 
 One of the limitations of the present study was the relatively short 
post-operative duration over which patients came for review. An important 
reason for this was that, in the absence of notable complications, patients 
felt it was not necessary to present for review. It is possible that if the 
follow-up period had been longer, the results may have been different. 
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Another limitation of the study is that the number of patients ultimately 
enrolled in the two study groups were less than that calculated for the 
sample size. Future studies are required to confirm the initial results of the 
present investigation. In these future studies, a larger number of patients 
should be enrolled and the study period should be extended.  
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Sl No Name IP No Age Sex Eye Asso.disease Surgery  type fundus Pre-op MT Post-op 1wk post-op 2week Post-op4week postop 3month Pre op vision post op vision surgical time SICS
1 Mary rani 770040 55 F LE Nil SICS LE NAD 160 160 154 153 150 0.5 0.6 11
2 sheba 847547 33 F LE Nil SICS LE NAD 160 170 172 167 164 0.1 0.6 12
3 chellakuty 824448 60 F RE NIL SICS RE NAD 173 183 183 178 174 0.5 0.6 11
4 sagunthala 845508 57 F RE NIL SICS RE NAD 160 175 169 160 162 0.5 1 10
5 chidambaram 836693 65 M RE NIL SICS RE NAD 156 170 168 165 165 0.1 0.8 9
6 parimanan 847525 62 M LE NIL SICS LE NAD 160 180 182 178 164 0.17 0.6 9
7 chellam 845480 55 F LE NIL SICS LE NAD 140 155 157 150 150 0.1 0.5 10
8 kamallam 845483 54 M LE NIL SICS LE NAD 155 170 177 163 160 0.08 0.6 10
9 amirtham 845509 59 F LE NIL SICS LE NAD 142 158 154 156 148 0.25 0.6 9
10 jesurathinam 847513 56 M RE NIL SICS RE NAD 160 168 167 158 156 0.1 0.6 10
11 velamkanni 837650 67 M RE NIL SICS RE NAD 150 160 159 154 156 0.08 0.6 9
12 gloriya 848660 68 M LE NIL SICS LE NAD 164 175 168 166 162 0.1 0.6 11
13 sarada 848679 60 F RE NIL SICS RE NAD 156 176 172 160 154 0.17 1 10
14 mariyasusai 850770 65 F LE NIL SICS LE NAD 174 168 172 170 170 0.1 0.6 9
15 rajamani 837154 60 F RE NIL SICS RE NAD 168 180 178 176 174 0.17 0.8 11
16 arokiyam 847084 60 F RE HT SICS RE NAD 165 177 173 176 175 0.32 0.6 10
17 manjaee 849936 52 M RE NIL SICS RE NAD 183 191 192 187 187 0.1 0.6 9
18 chellakuty 824448 60 F LE NIL SICS LE NAD 178 184 192 220 220 0.5 0.25 9
19 kannama 842133 41 F LE NIL SICSLE NAD 156 158 160 158 161 0.25 0.6 10
20 stephen 818699 56 M LE NIL SICSLE NAD 168 172 170 171 164 0.25 0.6 9
21 chinnaponu 830228 46 F RE NIL SICSRE NAD 158 162 164 156 156 0.08 0.6 10
22 stephen 818699 56 M RE NIL SICSRE NAD 153 160 161 158 160 0.17 1 11
23 velamkani 837650 67 M LE NIL SICS LE NAD 162 188 185 180 178 0.08 0.6 11
24 rajamani 837154 60 F LE NIL SICS LE NAD 173 184 179 175 177 0.32 0.8 10
25 manjaee 849936 52 F LE NIL SICS LE NAD 143 156 154 150 154 0.25 0.6 10
SICS GROUP
Sl No Name IP No Age Sex Eye Asso.disease Surgery  type fundus Pre-op MT Post-op 1wk post-op 2week Post-op4week postop 3month Pre op vision Post op vision surgical time phaco phaco time
1 Saraswathy 827678 60 F RE Nil Phaco RE NAD 182 190 178 175 175 0.5 1 10 1
2 Antonyammal 819574 75 F RE HT Phaco RE NAD 175 180 182 176 170 0.6 0.6 12 2
3 Tamilselvi 818075 40 F LE Nil Phaco LE NAD 163 182 177 174 160 0.5 0.6 9 1
4 Geetha 825338 51 F LE NIL Phaco LE NAD 202 215 198 197 190 0.5 0.8 9 2
5 Pitchaipillai 829253 51 M RE Nil Phaco RE NAD 204 200 196 197 194 0.6 0.8 11 1
6 Vembu 830846 40 F RE Nil Phaco RE NAD 163 170 169 162 170 0.32 0.6 10 1.5
7 Palanivel 830514 64 M LE Nil Phaco LE NAD 153 183 190 191 180 0.5 0.6 11 2
8 Narayanasamy 822673 78 M RE HT Phaco RE NAD 180 195 194 188 180 0.32 1 10 1.3
9 Phyllis 783111 69 F RE Nil Phaco RE NAD 148 158 162 164 164 0.5 1 12 1.2
10 Regana Begam 836808 57 F RE HT Phaco RE NAD 140 156 154 150 145 0.6 0.6 11 1.3
11 Motchamary 811294 55 F RE HT Phaco RE NAD 141 163 159 160 161 0.5 0.6 10 1
12 Ganthimathy 837942 45 F LE Nil Phaco LE NAD 165 180 183 178 164 0.25 0.8 9 1.4
13 masilamani 849294 61 M RE Nil phaco RE NAD 173 183 185 174 175 0.6 0.6 9 1
14 durai murgan 842024 35 M LE NIL phacoLE NAD 140 155 150 148 145 0.1 0.6 11 2
15 boopathi 845069 55 M LE NIL phacoLE NAD 145 160 168 155 156 0.1 0.6 12 1
16 ponnurangam 832168 65 F RE NIL phaco RE NAD 158 168 156 159 156 0.5 0.5 9 1
17 anbunasen 734071 73 M RE NIL phaco RE NAD 172 190 180 178 174 0.5 0.8 9 1
18 ganesamoorth 842143 62 M LE NIL PhacoLE NAD 167 162 164 165 164 0.1 0.5 13 1.3
19 thayagam 827693 61 M RE NIL phacoRE NAD 156 160 158 156 156 0.25 0.5 9 1
20 sudakar 813248 55 M RE NIL phacoRE NAD 160 171 168 168 164 0.17 0.6 11 1.5
21 kalaiselvi 826528 55 F LE NIL Phaco LE NAD 143 150 152 152 146 0.32 0.8 9 1
22 anbunasen 734071 73 M LE NIL phacoLE NAD 179 187 190 184 182 0.5 1 10 1
23 Antonyammal 819574 75 F LE HT Phaco LE NAD 180 175 174 168 170 0.6 0.8 11 1.3
24 Narayanasamy 822673 78 M LE HT Phaco LE NAD 161 180 178 165 160 0.32 0.6 10 1.2
25 pakiyam 826422 59 F RE NIL PhacoRE NAD 166 170 164 165 164 0.32 0.6 11 1
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